Alexza.com
Founded in 2000 and headquartered in Mountain View, California, Alexza Pharmaceuticals developed and commercialized products based on its proprietary Staccato system — a hand-held single-use inhaler delivering pure drug aerosols to the deep lung for rapid systemic delivery. Its lead commercial product was Adasuve (loxapine), an inhaled antipsychotic for acute agitation associated with schizophrenia or bipolar disorder. Alexza was acquired by Grupo Ferrer Internacional in June 2016 and now operates as part of the Ferrer group.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2014
Jul 2012
Dec 2006
Jan 2005
Jan 2005
Jul 2004
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
